bpc-157 safety data humans bpc 157 human clinical trial is being marketed as a “healing peptide” for tendon injuries, joint pain, gut repair, inflammation, The Hidden Risks of BPC‑157: – Preclinical safety evaluation of body

"Center for Veterinary Medicine Master" (PDF)

Clean the rubber stopper of the vial with an alcohol prep pad before inserting the needle

They act as hormones, neurotransmitters, immune messengers, and regulators of tissue repair

Presented for research literature review only Gujar AD et al

At Perfect B, tendon and ligament injuries are the most common reason patients request BPC-157

BPC-157 and Exercise: What to Expect in Daily Life on This Peptide At a glance Peptide class / 15-amino-acid gastric-derived sequence (BPC = Body Protection Compound) Typical research dose / 200 to 500 mcg per day, subcutaneous or intramuscular Primary studied benefit / tendon and ligament repair, muscle healing, GI mucosal protection Onset of reported effects / 2 to 6 weeks in most patient-reported outcome surveys Human RCT status / No Phase III RCTs published as of July 2025